Current status of the etiology and management of dysmenorrhea in adolescence.
D000293:Adolescent; D001241:Aspirin / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors; D004412:Dysmenorrhea / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D009288:Naproxen / Q000627:therapeutic use; D010060:Ovulation / Q000187:drug effects; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D011453:Prostaglandins / Q000096:biosynthesis; D014590:Uterine Contraction; D062367:ortho-Aminobenzoates / Q000627:therapeutic use
D003276:Contraceptives, Oral; D016861:Cyclooxygenase Inhibitors; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D062367:ortho-Aminobenzoates; D009288:Naproxen; C001209:fenamic acid; D001241:Aspirin; D007052:Ibuprofen; D007213:Indomethacin